Roivant Sciences Ltd (ROIV)

NASDAQ

$35.19

$+0.45

(+1.30%)

Regular Market

Roivant Sciences Ltd (ROIV) Live Price Chart

Last updated: ⁦2026-10-20 18:11:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Roivant Sciences Ltd (ROIV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $35.19, with a market capitalization of $24.22B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.28 to $42.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$24.22B
Open	$35.00
Day's High	$42.50
Day's Low	$2.52
Previous Close	$34.70
Volume	1.92M
Average Volume	7.16M
P/E Ratio	--
52-Week High	$42.50
52-Week Low	$17.28
Dividend Yield	--
Earnings Date	--

Roivant Sciences Ltd (ROIV) Stock Price Today

Roivant Sciences Ltd (ROIV) is currently trading at $35.19 as of 2026-10-20 17:54:42, up 1.40% ($0.49) from the previous close of $34.70

During today's regular trading session, ROIV has traded between $2.52 and $42.50, with a trading volume of 1.92M shares. The current price is near the upper end of today's range.

Roivant Sciences Ltd (ROIV) 7-Day Stock Price Change

Over the past seven days, Roivant Sciences Ltd (ROIV) moved from $35.44 to $35.19, representing a decline of 0.71% ($0.25).

The stock traded between $33.00 and $35.59 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 5.24 million shares, down versus the previous seven-day period, indicating lower trading activity.

ROIV 52-Week Price Position

Position in Range: 71.0%

52W Low$17.28

52W High$42.50

ROIV is currently trading at $35.19, placing it 71.0% of the way from its 52-week low of $17.28 to its 52-week high of $42.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Roivant Sciences Ltd (ROIV)?

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Ltd Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	721
Exchange	NASDAQ
Company Website	https://www.roivant.com

How to Buy Roivant Sciences Ltd (ROIV) Stock on MEXC

Eligible investors can buy real shares of Roivant Sciences Ltd (ROIV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ROIV and Place Your Order

Open the RealStocks trading page and search for ROIV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Roivant Sciences Ltd (ROIV) stock price today?

Roivant Sciences Ltd (ROIV) is currently trading at $ 35.19, up 1.40% ($0.49) from the previous close of $ 34.70. Intraday prices update in real time during regular trading hours.

2.Is ROIV stock going up or down today?

As of 2026-10-20 17:54:42, ROIV is trading at $ 35.19, up 1.40% ($0.49) from its previous close of $ 34.70. The stock has traded between $ 2.52 and $ 42.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is ROIV pre-market price?

As of 2026-10-20 17:54:42, ROIV is trading at $ 34.59 in pre-market trading, down 0.32% ($0.11) from the previous close of $ 34.70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ROIV after-hours price?

As of 2026-10-20 17:54:42, ROIV is trading at $ 34.53 in after-hours trading, down 0.50% ($0.18) from the regular-session close of $ 34.70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ROIV stock trading now?

ROIV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ROIV sit relative to its 52-week high and low?

Over the past 52 weeks, ROIV has traded between a low of $ 17.28 and a high of $ 42.50. At $ 35.19, the stock is positioned 71.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Roivant Sciences Ltd in?

Roivant Sciences Ltd (ROIV) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Roivant Sciences Ltd's market capitalization and where is it listed?

Roivant Sciences Ltd is listed on the NASDAQ exchange with a market capitalization of $ 24.22B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ROIV valued in terms of P/E ratio and EPS?

ROIV trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.37. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Roivant Sciences Ltd pay a dividend?

Roivant Sciences Ltd pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.